BeiGene Latest Chinese Biotech To Double Down On mRNA For Cancer

 
• By Dexter Jie Yan

Chinese biotechs have reached deals for cancer therapies to explore the novel uses of messenger RNA technology beyond COVID-19 vaccines, as the mRNA COVID-19 vaccine fame starts fading.

cancer vaccine
The deal with InnoRNA marks the second one BeiGene has signed in the mRNA field. • Source: Shutterstock

More from Business

More from Scrip